Australia's largest stock trading and investment forum Australia's #1 stock forum

AC8

Click for more information

0.00%

4.0¢ auscann group holdings ltd

Spot on mate, if I were performing a literature review on 'The...

First 16 Last

Share
Profile

Follow
Ryan34

81 Posts.

33

04/07/18

13:54

Post #: 34134501
Share

Originally posted by F18FDG ↑

I agree, it seems very strange, almost as if a second tier of investigation was layered over the original research project - that of effectiveness of prescribed opioids in non-cancer pain.

If one was to investigate 'use of cannabis', one would think standard measures of drug use: formulation, dosage, method of administration etc. would be integral to the study.

Seems their only measure was dosage - itself categorised into "not", "less frequent" and "daily or near daily", which is pretty weak imho . We are left to assume how these unquantifiable doses were administered to participants.

Clearly this was not a clinical trial, yet it leans toward clinical trial outcomes measures. Odd. Stewart was right to point out the value a clinical study can have.

imho, this paper adds little to the literature on therapeutic effectiveness of cannabis.

Expand

Spot on mate, if I were performing a literature review on 'The therapeutic effectiveness of cannabis" I would disregard this paper, or at best use it to demonstrate a 'gap in the literature'. It certainly looks like they have capitalised on the original research project to get another paper out of the deal.

AC8 Price at posting: $1.28 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

VUL

Vulcan appoints investment bank and M&A veteran to board

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

There are more pages in this discussion • 5 more messages in this thread...

First 16 Last

Add AC8 (ASX) to my watchlist

SPONSORED BY